financetom
Business
financetom
/
Business
/
CSX beats second-quarter profit on better volumes, strong pricing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CSX beats second-quarter profit on better volumes, strong pricing
Aug 5, 2024 2:38 PM

(Reuters) - U.S. railroad operator CSX narrowly beat second-quarter profit estimates on Monday, helped by higher shipment volumes and robust pricing, sending its shares up 5% after the bell.

Improving intermodal volumes, or goods moved via two or more modes of transport, have helped railroads squeeze out profits along with higher-than-inflation pricing, even as the overall freight industry continues to face a downturn.

CSX's revenue from intermodal shipments was $506 million in the reported quarter, 3% higher than a year ago.

The Jacksonville, Florida-based company reported revenue of $3.7 billion in the second quarter, in line with analysts' estimates.

It reported a profit of 49 cents per share, above analysts' estimate of 48 cents per share, according to LSEG data.

Its operating margin was 39.1% for the quarter, down 50 basis points from a year earlier.

CSX's east-coast competitor Norfolk Southern ( NSC ) also reported second-quarter profit above estimates last month, helped by higher pricing.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amgen to sell cholesterol drug at 60% discount direct to US consumers
Amgen to sell cholesterol drug at 60% discount direct to US consumers
Oct 6, 2025
* Drug will cost $239 a month via portal * Move follows July warning from Trump * Pharma companies under pressure to match lower prices in other countries By Deena Beasley LOS ANGELES, Oct 6 (Reuters) - Amgen ( AMGN ) on Monday launched direct-to-consumer U.S. sales of its cholesterol medication Repatha at a discounted cash price, becoming the latest...
Talkspace Buys Wisdo Health
Talkspace Buys Wisdo Health
Oct 6, 2025
09:03 AM EDT, 10/06/2025 (MT Newswires) -- Talkspace ( TALK ) said Monday it has acquired Wisdo Health, an AI-powered social health and peer support platform designed to help reduce loneliness and improve mental health. Financial terms weren't disclosed. The company said the platform uses machine learning to connect users with trained peers and moderated communities, and has demonstrated up...
Pagaya Technologies Closes $400 Million Asset-Backed Security Transaction; Shares Up Pre-Bell
Pagaya Technologies Closes $400 Million Asset-Backed Security Transaction; Shares Up Pre-Bell
Oct 6, 2025
09:00 AM EDT, 10/06/2025 (MT Newswires) -- Pagaya Technologies ( PGY ) said Monday that it closed a $400 million asset-backed security deal supported by auto loans from its network of auto lenders, including Ally and Westlake. The company said the transaction raised its cumulative auto ABS issuance for the year to approximately $1.7 billion. Shares of Pagaya Technologies (...
Arcutis Biotherapeutics Says Skin Disease Treatment for Children Ages 2 to 5 Gets US FDA Approval
Arcutis Biotherapeutics Says Skin Disease Treatment for Children Ages 2 to 5 Gets US FDA Approval
Oct 6, 2025
09:00 AM EDT, 10/06/2025 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Monday that the supplemental new drug application for Zoryve cream 0.05% for the topical treatment of skin disease atopic dermatitis in children aged two to five has received approval from the US Food and Drug Administration. The company said the once-daily cream can be used for any...
Copyright 2023-2026 - www.financetom.com All Rights Reserved